Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/Ib Trial of Single Agent ITR-251 in Patients With Advanced Solid Tumors With an Expansion-Phase in Metastatic Castration-Resistant Prostate Cancer

NCT07870096 is registered in ClinicalTrials.gov with ITERIA BIOPHARMA, S.L. as lead sponsor.

NCT NCT07870096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07870096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/Ib Trial of Single Agent ITR-251 in Patients With Advanced Solid Tumors With an Expansion-Phase in Metastatic Castration-Resistant Prostate Cancer
Lead sponsor
ITERIA BIOPHARMA, S.L.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
July 31, 2029
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration resistant metastatic prostate cancer, solid tumor cancer